To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Intraarticular Hyaluronic Acid Superior to Mepivacaine for Improving Pain and Function of Hip OA

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
July 2020

Intraarticular Hyaluronic Acid Superior to Mepivacaine for Improving Pain and Function of Hip OA

Vol: 9| Issue: 7| Number:24| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix®) injections versus local anesthetic in osteoarthritis of the hip

Arthritis Res Ther. 2009;11(6):R183.

Contributing Authors:
A Migliore U Massafra E Bizzi F Vacca S Martin-Martin M Granata A Alimonti S Tormenta

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Forty-two patients with hip osteoarthritis were randomized to receive an intra-articular injection of hyaluronic acid or local anesthetic (2% mepivacaine) for improving function and relief of pain. The primary outcome of interest was the Lequesne index. Secondary outcomes of interest include pain on a Visual Analog Scale (VAS), non-steroidal anti-inflammatory drug consumption, global physician ass...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue